SEC Form 4 · accession 0001209191-15-008154
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jan 30, 2015
Accepted (ET)
Feb 2, 2015 · 1:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 30, 2015 | C | 64,661 | $9.35 | A | 518,904 | I | By BMV Direct SO LP |
| Common StockF2 | Jan 30, 2015 | P | 26,543 | $11.00 | A | 545,447 | I | By BMV Direct SO LP |
| Common StockF1,F3 | Jan 30, 2015 | C | 317,409 | $9.35 | A | 1,896,982 | I | By BMV Direct SOTRS LP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8% Convertible Note Issued 9/9/13F2,F1 | — | Jan 30, 2015 | C | 337,150 | D | — | Mar 31, 2015 | Common Stock | 337,150 | 0 | I |
| 8% Convertible Note Issued 9/9/13F3,F1 | — | Jan 30, 2015 | C | 1,101,393 | D | — | Mar 31, 2015 | Common Stock | 1,101,393 | 0 | I |
| 8% Convertible Note Issued 2/26/14F2,F1 | — | Jan 30, 2015 | C | 267,446 | D | — | Mar 31, 2015 | Common Stock | 267,446 | 0 | I |
| 8% Convertible Note Issued 2/26/14F3,F1 | — | Jan 30, 2015 | C | 1,148,956 | D | — | Mar 31, 2015 | Common Stock | 1,148,956 | 0 | I |
| 8% Convertible Note Issued 12/2/14F3,F1 | — | Jan 30, 2015 | C | 717,437 | D | — | Mar 31, 2015 | Common Stock | 717,437 | 0 | I |
Explanation of responses
- F1The outstanding principal and accrued interest on these Convertible Notes were automatically converted into shares of the Issuer's Common Stock upon the closing of the Issuer's initial public offering at 85% of the Issuer's initial public offering price per share.
- F2BioMed Realty, L.P. (the "Partnership") is the sole general partner of BMV Direct SO LP. The sole general partner of the Partnership is BioMed Realty Trust, Inc. (the "REIT"). The REIT has sole voting and dispositive power with respect to the shares directly held by BMV Direct SO LP.
- F3BioMed Realty Holdings, Inc. ("Holdings") is the sole general partner of BMV Direct SOTRS LP. The sole shareholder of Holdings is the Partnership. The sole general partner of the Partnership is the REIT. The REIT has sole voting and dispositive power with respect to the shares directly held by BMV Direct SOTRS LP.